ID Source | ID |
---|---|
PubMed CID | 13055260 |
CHEBI ID | 179595 |
SCHEMBL ID | 7114188 |
MeSH ID | M0332087 |
Synonym |
---|
CHEBI:179595 |
tyrosyl-proline |
1-[2-amino-3-(4-hydroxyphenyl)propanoyl]pyrrolidine-2-carboxylic acid |
yp |
yp dipeptide |
tyrosylproline |
y-p dipeptide |
tyrosine proline dipeptide |
SCHEMBL7114188 |
VNYDHJARLHNEGA-UHFFFAOYSA-N |
tyrosine-proline dipeptide |
beta-casomorphin (1-2); b-casomorphin (1-2); l-tyrosyl-l-proline |
Excerpt | Reference | Relevance |
---|---|---|
"A replicate heart-cut column-switching HPLC method combined with two switching valves was newly developed for the simultaneous determination of three antihypertensive peptides (Ala-Phe, Tyr-Pro, and Trp-Tyr) in tryptic casein hydrolysate in one run-in assay." | ( Simultaneous determination of Angiotensin I-converting enzyme inhibitory peptides in tryptic casein hydrolysate by high-performance liquid chromatography combined with a replicate heart-cut column-switching technique. Matsui, T; Matsumoto, K; Shiraishi, K; Ueki, T; Watanabe, K; Zhu, XL, 2007) | 0.34 |
Class | Description |
---|---|
dipeptide | Any molecule that contains two amino-acid residues connected by peptide linkages. |
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res] |
Timeframe | Studies, This Drug (%) | All Drugs % |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (14.29) | 18.2507 |
2000's | 2 (28.57) | 29.6817 |
2010's | 4 (57.14) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] |
Publication Type | This drug (%) | All Drugs (%) |
---|---|---|
Trials | 0 (0.00%) | 5.53% |
Reviews | 1 (12.50%) | 6.00% |
Case Studies | 0 (0.00%) | 4.05% |
Observational | 0 (0.00%) | 0.25% |
Other | 7 (87.50%) | 84.16% |
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] |